Voronoi Inc
KOSDAQ:310210
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Voronoi Inc
KOSDAQ:310210
|
KR |
|
Playtika Holding Corp
NASDAQ:PLTK
|
IL |
|
C
|
CAB Cakaran Corporation Bhd
KLSE:CARLSBG
|
MY |
|
S
|
Soosan INT Co Ltd
KOSDAQ:050960
|
KR |
|
Solvar Ltd
ASX:SVR
|
AU |
|
MGM China Holdings Ltd
HKEX:2282
|
MO |
|
J
|
Jumbo SA
ATHEX:BELA
|
GR |
|
C
|
Changchun Engley Automobile Industry Co Ltd
SSE:601279
|
CN |
|
Evergrande Property Services Group Ltd
HKEX:6666
|
CN |
Voronoi Inc
Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
Voronoi, Inc. engages in the manufacture of novel kinase inhibitors and target protein degrader drugs. The company is headquartered in Incheon, Incheon. The company went IPO on 2022-06-24. The firm is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The firm is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
